175 related articles for article (PubMed ID: 33996230)
1. Understanding the sources of errors in
Wang R; Alvarez DA; Crouch BT; Pilani A; Lam C; Zhu C; Hughes P; Katz D; Haystead T; Ramanujam N
Biomed Opt Express; 2021 Apr; 12(4):2299-2311. PubMed ID: 33996230
[TBL] [Abstract][Full Text] [Related]
2. Exploiting heat shock protein expression to develop a non-invasive diagnostic tool for breast cancer.
Crouch BT; Gallagher J; Wang R; Duer J; Hall A; Soo MS; Hughes P; Haystead T; Ramanujam N
Sci Rep; 2019 Mar; 9(1):3461. PubMed ID: 30837677
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition.
Pastorek M; Muller P; Coates PJ; Vojtesek B
PLoS One; 2018; 13(8):e0202758. PubMed ID: 30138434
[TBL] [Abstract][Full Text] [Related]
4. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
5. Short-hairpin RNA-mediated Heat shock protein 90 gene silencing inhibits human breast cancer cell growth in vitro and in vivo.
Zuo K; Li D; Pulli B; Yu F; Cai H; Yuan X; Zhang X; Lv Z
Biochem Biophys Res Commun; 2012 May; 421(2):396-402. PubMed ID: 22521890
[TBL] [Abstract][Full Text] [Related]
6.
Osada T; Kaneko K; Gwin WR; Morse MA; Hobeika A; Pogue BW; Hartman ZC; Hughes PF; Haystead T; Lyerly HK
Clin Cancer Res; 2017 Dec; 23(24):7531-7542. PubMed ID: 28993342
[No Abstract] [Full Text] [Related]
7. NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models.
Jensen MR; Schoepfer J; Radimerski T; Massey A; Guy CT; Brueggen J; Quadt C; Buckler A; Cozens R; Drysdale MJ; Garcia-Echeverria C; Chène P
Breast Cancer Res; 2008; 10(2):R33. PubMed ID: 18430202
[TBL] [Abstract][Full Text] [Related]
8. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
[TBL] [Abstract][Full Text] [Related]
9. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
[TBL] [Abstract][Full Text] [Related]
10. Exercise-heat acclimation in humans alters baseline levels and ex vivo heat inducibility of HSP72 and HSP90 in peripheral blood mononuclear cells.
McClung JP; Hasday JD; He JR; Montain SJ; Cheuvront SN; Sawka MN; Singh IS
Am J Physiol Regul Integr Comp Physiol; 2008 Jan; 294(1):R185-91. PubMed ID: 17977914
[TBL] [Abstract][Full Text] [Related]
11. Leveraging ectopic Hsp90 expression to assay the presence of tumor cells and aggressive tumor phenotypes in breast specimens.
Crouch B; Murphy H; Belonwu S; Martinez A; Gallagher J; Hall A; Soo MS; Lee M; Hughes P; Haystead T; Ramanujam N
Sci Rep; 2017 Dec; 7(1):17487. PubMed ID: 29235516
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model.
Spiegelberg D; Mortensen AC; Selvaraju RK; Eriksson O; Stenerlöw B; Nestor M
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):974-982. PubMed ID: 26627081
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 mediates cytoprotection by H₂S against chemical hypoxia-induced injury in PC12 cells.
Meng JL; Mei WY; Dong YF; Wang JH; Zhao CM; Lan AP; Yang CT; Chen PX; Feng JQ; Hu CH
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):42-9. PubMed ID: 21083699
[TBL] [Abstract][Full Text] [Related]
14. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
Håvik B; Bramham CR
Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis, biological evaluation and preliminary microPET study of
Kang J; Young Lee J; Taş İ; More KN; Kim H; Park JH; Chang DJ
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3658-3664. PubMed ID: 30528977
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of heat stress-related apoptosis of chicken myocardial cells through inducing Hsp90 expression by aspirin administration in vivo.
Zhang X; Zhang M; Su Y; Wang Z; Zhao Q; Zhu H; Qian Z; Xu J; Tang S; Wu D; Lin Y; Kemper N; Hartung J; Bao E
Br Poult Sci; 2018 Jun; 59(3):308-317. PubMed ID: 29557194
[TBL] [Abstract][Full Text] [Related]
17. Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer.
Terwisscha van Scheltinga AG; Berghuis P; Nienhuis HH; Timmer-Bosscha H; Pot L; Gaykema SB; Lub-de Hooge MN; Kosterink JG; de Vries EG; Schröder CP
Eur J Cancer; 2014 Sep; 50(14):2508-16. PubMed ID: 25027745
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic Acid-mediated Inhibition of Heat Shock Protein 90-p23 Chaperone Complex and Downstream Client Proteins in Lung and Breast Cancer.
Mouradian M; Ma IV; Vicente ED; Kikawa KD; Pardini RS
Nutr Cancer; 2017 Jan; 69(1):92-104. PubMed ID: 27880046
[TBL] [Abstract][Full Text] [Related]
19. PET imaging of Hsp90 expression in pancreatic cancer using a new
Wang X; Zhang J; Wu H; Li Y; Conti PS; Chen K
Amino Acids; 2018 Jul; 50(7):897-907. PubMed ID: 29691700
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer.
Kou X; Jiang X; Liu H; Wang X; Sun F; Han J; Fan J; Feng G; Lin Z; Jiang L; Yang Y
Cancer Sci; 2018 Oct; 109(10):3272-3284. PubMed ID: 30039622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
